UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reduced Cardiotoxicity and Preserved Antitumor Efficacy of Liposome-Encapsulated Doxorubicin and Cyclophosphamide Compared With Conventional Doxorubicin and Cyclophosphamide in a Randomized, Multicenter Trial of Metastatic Breast Cancer

Journal of clinical oncology, 2001-03, Vol.19 (5), p.1444-1454

2001

Volltextzugriff (PDF)

Can Altering the Delivery Technique of PMRT Reduce Complication Rates for Patients With Staged Reconstruction in an Urban Population?

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E27-E27

2015

Volltextzugriff (PDF)

The Use of Radiation Therapy Does Not Appear to Have an Impact on the Incidence of Heart Failure in Patients Receiving Targeted HER2 Based Systemic Therapy

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E42-E42

2015

Volltextzugriff (PDF)

New archaeal methyltransferases forming 1-methyladenosine or 1-methyladenosine and 1-methylguanosine at position 9 of tRNA

Nucleic acids research, 2010-10, Vol.38 (19), p.6533-6543

2010

Volltextzugriff (PDF)

Radiation Lumpectomy Boost and Acute Treatment Toxicities in Patients With or Without Reduction Mammoplasty as Part of Breast Conserving Treatment

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E26-E26

2015

Volltextzugriff (PDF)

Preoperative Partial Breast Radiation Therapy: Short-term Imaging Outcomes With Two Unique Treatment Regimens

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E46-E46

2015

Volltextzugriff (PDF)

Preoperative Accelerated Partial Breast Radiation Is Associated With Decreased Cd8+ Cells in Patients With Early Breast Cancer

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S243-S243

2012

Volltextzugriff (PDF)

Near 25% Complete Pathologic Response Following Preoperative Accelerated Partial Breast Radiation Therapy (APBI) Using 3-dimensional Conformal Radiation Therapy (3D CRT)

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S240-S240

2012

Volltextzugriff (PDF)

Can Breast MRI Select Patients for Treatment With Preoperative APBI?

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S244-S244

2012

Volltextzugriff (PDF)

Brachytherapy Based Accelerated Partial Breast Irradiation: A Patterns of Care Analysis with ASTRO Consensus Statement Groupings

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S215-S216

2011

Volltextzugriff (PDF)

Social support as a buffer to the psychological impact of stressful life events in women with breast cancer

Cancer, 2001-01, Vol.91 (2), p.443-454

2001

Volltextzugriff (PDF)

Preliminary Results of a Prospective Feasibility Study Testing Preoperative Accelerated Partial Breast Radiotherapy (APBI) Using 3 Dimensional Conformal Radiotherapy (3D CRT)

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S264-S264

2011

Volltextzugriff (PDF)

Equivalent Survival with Breast Conservation Therapy or Mastectomy in the Management of Young Women with Early-stage Breast Cancer

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S32-S33

2011

Volltextzugriff (PDF)

Local Therapy in the Management of Occult Primary Breast Cancer

International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S159-S160

2010

Volltextzugriff (PDF)

Update on taxane development: new analogs and new formulations

Drug design, development and therapy, 2012, Vol.6 (default), p.371-384

2012

Volltextzugriff (PDF)

Structure of isochorismate synthase DhbC from Bacillus anthracis

Acta crystallographica. Section F, Structural biology and crystallization communications, 2013-09, Vol.69 (9), p.956-961

2013

Volltextzugriff (PDF)

Pre-operative Therapy Increases Patient Eligibility for Accelerated Partial Breast Irradiation (APBI) and Decreases Normal Tissue Exposure

International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S251-S251

2010

Volltextzugriff (PDF)

Abstract P2-02-10: Circulating level of GP88/Progranulin is associated with clinical outcome and overall survival in stage 4 breast cancer patients

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P2-P2-02-10

2018

Volltextzugriff (PDF)

Abstract P5-13-02: Chemoprevention utilization in patients with a history of atypical hyperplasia, atypical lobular hyperplasia, or lobular carcinoma in-situ: A retrospective chart review of patients diagnosed at an urban hospital with a large minority patient population

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P5-P5-13-02

2018

Volltextzugriff (PDF)

SGNLVA-002: Single arm, open label, phase Ib/II study of ladiratuzumab vedotin (LV) in combination with pembrolizumab for first-line treatment of patients with unresectable locally-advanced or metastatic triple-negative breast cancer

Annals of oncology, 2019-05, Vol.30, p.iii63-iii63

2019

Volltextzugriff (PDF)

Suramin, an Active Drug for Prostate Cancer: Interim Observations in a Phase I Trial

JNCI : Journal of the National Cancer Institute, 1993-04, Vol.85 (8), p.611-621

1993

Volltextzugriff (PDF)

Abstract P3-02-08: Association of background parenchymal enhancement with breast cancer risk factors and tumor characteristics

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P3-P3-02-08

2017

Volltextzugriff (PDF)

Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer

Journal of clinical oncology, 1995-09, Vol.13 (9), p.2174-2186

1995

Volltextzugriff (PDF)

196TiPSGNLVA-002: Single arm, open label, phase Ib/II study of ladiratuzumab vedotin (LV) in combination with pembrolizumab for first-line treatment of patients with unresectable locally-advanced or metastatic triple-negative breast cancer

Annals of oncology, 2019-05, Vol.30 (Supplement_3)

2019

Volltextzugriff (PDF)

1 – 25 von 135

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(129)
Mit Volltextzugriff
(128)

Publikationsform

Artikel
(130)
Berichte
(5)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Life Sciences & Biomedicine
(44)
Humans
(32)
Oncology
(27)
Female
(26)
Middle Aged
(26)
Aged
(23)
Adult
(22)
Breast Cancer
(16)
Biological And Medical Sciences
(15)
Chemotherapy
(14)
Medical Sciences
(14)
Breast Neoplasms - Drug Therapy
(13)
Hematology, Oncology And Palliative Medicine
(13)
Radiology
(13)
Antineoplastic Agents
(12)
Male
(11)
Pharmacology. Drug Treatments
(11)
Breast Neoplasms - Pathology
(10)
Biochemistry & Molecular Biology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Reduced Cardiotoxicity and Preserved Antitumor Efficacy of Liposome-Encapsulated Doxorubicin and Cyclophosphamide Compared With Conventional Doxorubicin and Cyclophosphamide in a Randomized, Multicenter Trial of Metastatic Breast Cancer

Can Altering the Delivery Technique of PMRT Reduce Complication Rates for Patients With Staged Reconstruction in an Urban Population?

The Use of Radiation Therapy Does Not Appear to Have an Impact on the Incidence of Heart Failure in Patients Receiving Targeted HER2 Based Systemic Therapy

New archaeal methyltransferases forming 1-methyladenosine or 1-methyladenosine and 1-methylguanosine at position 9 of tRNA

Radiation Lumpectomy Boost and Acute Treatment Toxicities in Patients With or Without Reduction Mammoplasty as Part of Breast Conserving Treatment

Preoperative Partial Breast Radiation Therapy: Short-term Imaging Outcomes With Two Unique Treatment Regimens

Preoperative Accelerated Partial Breast Radiation Is Associated With Decreased Cd8+ Cells in Patients With Early Breast Cancer

Near 25% Complete Pathologic Response Following Preoperative Accelerated Partial Breast Radiation Therapy (APBI) Using 3-dimensional Conformal Radiation Therapy (3D CRT)

Can Breast MRI Select Patients for Treatment With Preoperative APBI?

Brachytherapy Based Accelerated Partial Breast Irradiation: A Patterns of Care Analysis with ASTRO Consensus Statement Groupings

Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial

Social support as a buffer to the psychological impact of stressful life events in women with breast cancer

Preliminary Results of a Prospective Feasibility Study Testing Preoperative Accelerated Partial Breast Radiotherapy (APBI) Using 3 Dimensional Conformal Radiotherapy (3D CRT)

Equivalent Survival with Breast Conservation Therapy or Mastectomy in the Management of Young Women with Early-stage Breast Cancer

Local Therapy in the Management of Occult Primary Breast Cancer

Update on taxane development: new analogs and new formulations

Structure of isochorismate synthase DhbC from Bacillus anthracis

Pre-operative Therapy Increases Patient Eligibility for Accelerated Partial Breast Irradiation (APBI) and Decreases Normal Tissue Exposure

Abstract P2-02-10: Circulating level of GP88/Progranulin is associated with clinical outcome and overall survival in stage 4 breast cancer patients

Abstract P5-13-02: Chemoprevention utilization in patients with a history of atypical hyperplasia, atypical lobular hyperplasia, or lobular carcinoma in-situ: A retrospective chart review of patients diagnosed at an urban hospital with a large minority patient population

SGNLVA-002: Single arm, open label, phase Ib/II study of ladiratuzumab vedotin (LV) in combination with pembrolizumab for first-line treatment of patients with unresectable locally-advanced or metastatic triple-negative breast cancer

Suramin, an Active Drug for Prostate Cancer: Interim Observations in a Phase I Trial

Abstract P3-02-08: Association of background parenchymal enhancement with breast cancer risk factors and tumor characteristics

Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer

196TiPSGNLVA-002: Single arm, open label, phase Ib/II study of ladiratuzumab vedotin (LV) in combination with pembrolizumab for first-line treatment of patients with unresectable locally-advanced or metastatic triple-negative breast cancer

Suchergebnisse filtern